Accuray Inc (NAS:ARAY)
$ 1.62 -0.07 (-4.14%) Market Cap: 160.65 Mil Enterprise Value: 314.13 Mil PE Ratio: 0 PB Ratio: 3.95 GF Score: 70/100

Accuray Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 06:00PM GMT
Release Date Price: $3.25 (+7.26%)
Eleni Maria Apostolatos
JP Morgan Chase & Co, Research Division - Research Analyst

My name is Eleni, and I am on the life sciences team. It is my pleasure to introduce our next company, Accuray. As a reminder, we will be hosting a breakout session in the Yorkshire Room following the presentation.

And with that, let me hand it off to Josh.

Joshua H. Levine
Accuray Incorporated - President, CEO & Director

Thanks, Eleni. Thank you for -- everyone for being here and having an interest in our discussion.

Here is a real quick look at my agenda this morning. This is going to be a presentation quite frankly that I have been waiting probably 5 or 6 years to give because it represents a very, very different Accuray than you've seen or heard about and come to expect in the recent or intermediate past, call it. Very heavy focus on what's driving our growth and expanded revenue, momentum opportunities. We'll talk about China, talk some more about our platforms. A very big piece of catalyst, if you will, is the alternative payment model that CMS

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot